← Eichor
Study identifier: NCT05886114 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Condition: Cognitive Impairment · Alzheimer Disease · Vascular Cognitive Impairment  ·  Sponsor: Zhejiang University

PhaseNA
Planned participants1200
Who can joinAll sexes, 60 Years to 80 Years
Healthy volunteersYes

About this study

A study conducted in Finland discovered that a multidomain intervention, consisting of physical activity, nutritional guidance, cognitive training, social activities, and management of vascular risk factors, effectively decelerated cognitive decline in healthy older adults who were at an increased risk of cognitive decline. The HERITAGE study is a 2-year clustered randomized controlled trial (clustered-RCT) that explores the efficacy of a multidomain intervention among 1200 elderly residents with a higher risk of cognitive decline and dementia in Zhejiang Province, China

This description comes directly from the study's public registry record.

Talk to the study team

Xin Xu, PhD  ·  +8613575760802  ·  xuxinsummer@zju.edu.cn

Changzheng Yuan, PhD  ·  chy478@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

School of Public Health and The Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, ChinaHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05886114